The Wnt signaling pathway is hyperactivated in most colorectal cancers (CRC). Finding new regulators of this pathway represents the potential for cancer diagnosis or treatment. OCC-1 was initially reported as an up-regulated gene in colon carcinoma， without knowing its mechanism of action. Here， two novel transcript variants and an exonic microRNA that originated from the OCC-1 gene are reported， showing positive effects on Wnt activity. Up-regulation of the known OCC-1 variant (assigned as OCC-1A/B) was limited to CRC， and its overexpression increased survival of CRC-originated SW480 cells (Wnt)， while resulting in apoptosis of Wnt-suppressed SW480 cells or HeLa cells (Wnt) detected by PI staining. I... More
The Wnt signaling pathway is hyperactivated in most colorectal cancers (CRC). Finding new regulators of this pathway represents the potential for cancer diagnosis or treatment. OCC-1 was initially reported as an up-regulated gene in colon carcinoma， without knowing its mechanism of action. Here， two novel transcript variants and an exonic microRNA that originated from the OCC-1 gene are reported， showing positive effects on Wnt activity. Up-regulation of the known OCC-1 variant (assigned as OCC-1A/B) was limited to CRC， and its overexpression increased survival of CRC-originated SW480 cells (Wnt)， while resulting in apoptosis of Wnt-suppressed SW480 cells or HeLa cells (Wnt) detected by PI staining. Immunocytochemistry showed that the OCC-1A/B-encoded peptide was localized to the nucleus， where its overexpression resulted in Wnt signaling up-regulation， detected by TOP/FOPflash assay. The noncoding portion of the OCC-1A/B transcript had a suppressive effect on Wnt activity and had a negative correlation with APPL2 neighboring gene expression. Unlike OCC-1A/B， the novel OCC-1C splice variant had no expression alteration in CRC， and it seemed to encode a smaller peptide with cytoplasmic localization. A 60-nucleotide (nt) fragment containing an AUG start codon is spliced out to produce an OCC-1D noncoding RNA variant. The 60-nt RNA was validated as the precursor of a novel microRNA， which we named miR-ex1 Both OCC-1D and miR-ex1 were coordinately up-regulated in CRC. MiR-ex1 functional analysis revealed that it is targeting the APC2 tumor suppressor gene and is an activator of the Wnt signaling pathway. Overall， the OCC-1 gene is now introduced as a novel Wnt signaling regulator and as a potential therapeutic target.
